Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery

Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery

Botulinum toxin (BT) is used to treat pediatric patients with Hirschsprung disease (HD) with obstructive symptoms. We aimed to characterize use of BT in HD patients across pediatric colorectal surgery referral centers. A multicenter retrospective study of BT use in children (0–18y) with HD was perfo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pediatric surgery 2022-06, Vol.57 (6), p.1033-1039
Hauptverfasser: Rice-Townsend, Samuel E., Nicassio, Lauren, Glazer, Debra, Avansino, Jeffrey, Durham, Megan M., Calkins, Casey M., Rentea, Rebecca M., Ralls, Matthew W., Wood, Richard J., Rollins, Michael D., Garvey, Erin M., Lewis, Katelyn E., Reeder, Ron, Smith, Caitlin A.
Format: Artikel
Sprache:eng
Schlagworte:
Botox
Botulinum toxin
Botulinum Toxins
Botulinum Toxins, Type A - therapeutic use
Child
Colorectal Surgery
Constipation
Endorectal pullthrough
Hirschsprung disease
Hirschsprung Disease - surgery
Humans
Referral and Consultation
Retrospective Studies
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Botulinum toxin (BT) is used to treat pediatric patients with Hirschsprung disease (HD) with obstructive symptoms. We aimed to characterize use of BT in HD patients across pediatric colorectal surgery referral centers. A multicenter retrospective study of BT use in children (0–18y) with HD was performed using the Pediatric Colorectal and Pelvic Learning Consortium (PCPLC) between 2017 and 2021. Sites with
ISSN:0022-3468
1531-5037
DOI:10.1016/j.jpedsurg.2022.02.005